Shigeo Yamaguchi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Identification of BRAF Inhibitor Resistance-associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening.
Journal: Anticancer research
Published: March 21, 2024
Effectiveness of Changing the Class of Molecularly Targeted Agent after Disease Progression during Initial Molecularly Targeted Therapy for Luminal Advanced/Metastatic Breast Cancer.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Published: February 23, 2023
TP53 Signature Score Predicts Prognosis and Immune Response in Triple-negative Breast Cancer.
Journal: Anticancer research
Published: January 21, 2023
ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?
Journal: Annals of surgical oncology
Published: June 02, 2022
The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer.
Journal: Anticancer research
Published: February 25, 2022
Elevation of the Prognostic Factor Plasma Fibrinogen Reflects the Immunosuppressive Tumor Microenvironment in Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: January 31, 2022
Molecular Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor 2-Negative Metastatic Breast Cancer in Clinical Practice.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Published: April 19, 2021
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.
Journal: Breast cancer research and treatment
Published: September 29, 2020
Identification of the mutation signature of the cancer genome caused by irradiation.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 24, 2020
Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Journal: Clinical orthopaedics and related research
Published: June 23, 2020
A novel diagnostic system to evaluate epidermal growth factor receptor impact as a prognostic and therapeutic indicator for lung adenocarcinoma.
Journal: Scientific reports
Published: December 04, 2019
Last Updated: 09/26/2026